503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-11.07%
Revenue decline while CRWD shows 5.94% growth. Joel Greenblatt would examine competitive position erosion.
-29.08%
Cost reduction while CRWD shows 7.31% growth. Joel Greenblatt would examine competitive advantage.
-7.18%
Gross profit decline while CRWD shows 5.45% growth. Joel Greenblatt would examine competitive position.
4.38%
Margin expansion while CRWD shows decline. John Neff would investigate competitive advantages.
4.94%
R&D growth 1.25-1.5x CRWD's 3.75%. Martin Whitman would scrutinize investment rationale.
128.01%
G&A growth above 1.5x CRWD's 7.72%. Michael Burry would check for operational inefficiency.
-2.24%
Marketing expense reduction while CRWD shows 1.68% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
18.83%
Operating expenses growth above 1.5x CRWD's 3.48%. Michael Burry would check for inefficiency.
3.66%
Similar total costs growth to CRWD's 4.38%. Walter Schloss would investigate norms.
No Data
No Data available this quarter, please select a different quarter.
161.11%
D&A growth while CRWD reduces D&A. John Neff would investigate differences.
-29.90%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-21.13%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-29.90%
Operating income decline while CRWD shows 9.37% growth. Joel Greenblatt would examine position.
-21.17%
Operating margin decline while CRWD shows 14.45% growth. Joel Greenblatt would examine position.
18.10%
Similar other expenses growth to CRWD's 18.80%. Walter Schloss would investigate industry patterns.
-26.00%
Pre-tax income decline while CRWD shows 20.26% growth. Joel Greenblatt would examine position.
-16.79%
Pre-tax margin decline while CRWD shows 24.73% growth. Joel Greenblatt would examine position.
-26.03%
Both companies reducing tax expense. Martin Whitman would check patterns.
-25.99%
Net income decline while CRWD shows 29.52% growth. Joel Greenblatt would examine position.
-16.77%
Net margin decline while CRWD shows 33.47% growth. Joel Greenblatt would examine position.
-25.00%
EPS decline while CRWD shows 29.55% growth. Joel Greenblatt would examine position.
-28.13%
Diluted EPS decline while CRWD shows 29.55% growth. Joel Greenblatt would examine position.
-0.19%
Share count reduction while CRWD shows 0.59% change. Joel Greenblatt would examine strategy.
-0.23%
Diluted share reduction while CRWD shows 0.59% change. Joel Greenblatt would examine strategy.